Neuland Laboratories is currently trading at Rs. 263.00, up by 8.95 points or 3.52% from its previous closing of Rs. 254.05 on the BSE.
The scrip opened at Rs. 263.00 and has touched a high and low of Rs. 265.00 and Rs. 262.00 respectively. So far 62 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 370.40 on 19-Dec-2013 and a 52 week low of Rs. 88.50 on 13-Jun-2013.
Last one week high and low of the scrip stood at Rs. 269.00 and Rs. 253.00 respectively. The current market cap of the company is Rs. 204.14 crore.
The promoters holding in the company stood at 50.06% while Institutions and Non-Institutions held 0.09% and 49.85% respectively.
Neuland Laboratories has opened a new manufacturing facility constructed as part of its collaboration with Tokyo-based API Corporation (APIC), a healthcare unit of Mitsubishi Chemical Holdings Group that produces APIs, intermediates and investigational new drugs, along with fine chemicals and reagents.
The new facility, which is located in a Neuland complex in Pashamylaram, Hyderabad, is the first manufacturing facility that APIC has established outside of Japan. Pursuant to an agreement entered into in March, 2013, Neuland constructed and will operate these manufacturing facilities dedicated to providing APIC with capacity for meeting the needs of its customers for pharmaceutical APIs and intermediates.
Neuland Laboratories is a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and contract manufacturing services to customers located in 85 countries. Its manufacturing facilities are inspected and approved by the US FDA and other leading regulatory agencies.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1804.65 |
Dr. Reddys Lab | 1209.00 |
Cipla | 1503.40 |
Lupin | 2107.30 |
Zydus Lifesciences | 964.95 |
View more.. |